Caleb Moore
Internal Medicine · Waterbury, CTNPI 1366461790
Payments from drug & device makers
Across 118 payments — averaging $37.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Butterfly Network, Inc.$2K
- AbbVie$583
- Pfizer$354
- Novo Nordisk$319
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$151
- Exact Sciences$122
- plus $882 from 21 others
What the payments were for
- Food & beverage$2,41054%
- Gifts$2,02846%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Butterfly Network, Inc. | 1 | $2,028 |
| AbbVie | 25 | $583 |
| Pfizer | 18 | $354 |
| Novo Nordisk | 17 | $319 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 8 | $151 |
| Exact Sciences | 4 | $122 |
| Eisai Inc. | 1 | $121 |
| GSK | 6 | $99 |
| AstraZeneca | 7 | $99 |
| Merck | 4 | $75 |
| Lilly USA, LLC | 2 | $63 |
| Kowa Pharmaceuticals America, Inc. | 4 | $52 |
| Amgen(2 entities) | 2 | $43 |
| Sanofi Pasteur Inc. | 3 | $42 |
| Novartis | 2 | $33 |
| CSL Behring | 1 | $30 |
| Genentech USA, Inc. | 2 | $29 |
| Amarin Pharma, Inc. | 2 | $26 |
| E.r. Squibb & Sons, L.L.C. | 1 | $25 |
| Halozyme Inc | 1 | $23 |
| Astellas Pharma US Inc | 1 | $22 |
| Seqirus USA Inc | 1 | $21 |
| Boehringer Ingelheim | 1 | $19 |
| Cleerly, Inc. | 1 | $19 |
| Phadia US Inc. | 1 | $15 |
| Medtronic | 1 | $15 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Butterfly iQ$2,028
- Leqembi$121
How this compares
$4,438 in reported general payments places this provider in the 90th percentile of 2,067 internal medicine providers in Connecticut.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 18 | $20,300 |
| OzempicSemaglutide | 14 | $18,037 |
| Atorvastatin Calcium | 78 | $950 |
| Rosuvastatin Calcium | 53 | $856 |
| Lisinopril | 65 | $573 |
| Pravastatin Sodium | 22 | $559 |
| Tamsulosin Hcl | 12 | $364 |
| Losartan Potassium | 13 | $325 |
| Amlodipine Besylate | 33 | $310 |
| Irbesartan | 18 | $307 |
| Levothyroxine Sodium | 28 | $296 |
| Celecoxib | 19 | $289 |
| Metoprolol Succinate | 14 | $262 |
| Allopurinol | 22 | $226 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 11 | $161 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $354 | $20,30018 claims |
| Novo NordiskOzempic | $319 | $18,03714 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,067 internal medicine providers in Connecticut.
Other internal medicine in Waterbury
- Joseph SouferWaterbury$21.5M
- Elie HelouWaterbury$184K
- Oltjon AlbajramiWaterbury$57K
- David RadinStamford$7M
- Steven RyderWestport$3.9M
- Nancy BrownNew Haven$2.8M
- Charles MontanoCromwell$2.8M
- Arthur DecillisMadison$1M
- Michelle MallitzTrumbull$971K
- Allen HellerWoodbridge$758K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.